Pharmamarketeer
wet- en regelgeving

FDA grants authorization for Pfizer COVID-19 vaccine for children aged 5 to 11

1 november 2021
Redactie
FDA grants authorization for Pfizer COVID-19 vaccine for children aged 5 to 11

The Food and Drug Administration has authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use in kids aged 5 to 11, making it the first vaccine in the U.S. to be authorized for young children.

The agency decided the vaccine, which is given as one-third of the adult dose, is safe and effective in young children after reviewing the data, FDA acting commissioner Janet Woodcock said in a statement.

Lees dit artikel verder op: FDA grants authorization for Pfizer COVID-19 vaccine for children aged 5 to 11 – News – MM+M – Medical Marketing and Media (mmm-online.com)

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)